The FDA states that salt forms such as semaglutide sodium and semaglutide acetate are different active ingredients from the one used in the approved drugs, that it does not have information on whether they share the same chemical and pharmacologic properties, and that it is not aware of any lawful basis for their use in compounding
Monthly weigh-ins and quarterly lab tests provide appropriate monitoring frequency for most individuals
If it is #musclemass, retention (M- maintain muscle) or attenuation, we do not have that evidence
Oral GLP-1 medications may cause similar side effects as GLP-1 injectables, such as nausea, vomiting and diarrhea
Most tracking systems provide detailed information about order progress, including shipping milestones and delivery confirmation
For anyone tracking their GLP-1 related energy levels and metabolic markers, butyrate production is one of the most important metrics of gut health that rarely gets discussed outside of specialized research circles